Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
Top Cited Papers
- 23 March 2005
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 149 (3) , 548-557
- https://doi.org/10.1016/j.ahj.2004.09.033
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular DysfunctionCirculation, 2003
- Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial FibrillationCirculation, 2002
- New ideas about atrial fibrillation 50 years onNature, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-responseJournal of the American College of Cardiology, 2000
- Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillationJournal of the American College of Cardiology, 2000
- Amiodarone to Prevent Recurrence of Atrial FibrillationNew England Journal of Medicine, 2000
- Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trialsJournal of the American College of Cardiology, 1998
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant DataJournal of the American Statistical Association, 1974